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Abstract 
Rheumatoid Arthritis (RA) is a chronic autoimmune disease characterised by high grade-
inflammation, and associated with elevated cardiovascular risk, rheumatoid-cachexia and 
functional impairment. Sedentary behaviour is linked to heightened inflammation, and is 
highly pervasive in RA -likely as a result of compromised physical function and persistent 
fatigue. This high sedentarity may exacerbate the inflammatory process in RA, and hold 
relevance for disease-related outcomes. The aim of this narrative review is to provide an 
overview of the definition, measurement and health relevance of sedentary behaviour in the 
 context of RA. Contradictions are highlighted with regards to the manner in which sedentary 
behaviour is operationalized, and the significance of sedentary behaviour physiology for 
disease-outcomes in RA is outlined. The advantages and disadvantages of sedentary 
behaviour measurement approaches are also discussed. Against this background, we 
summarise studies that have reported sedentary behaviour and its health correlates in RA, and 
propose directions for future research. 
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Key messages:  
 
 Sedentary behaviour may exacerbate already heightened inflammation in RA and hold 
relevance for disease-related outcomes. 
 Studies investigating sedentary behaviour in RA are limited by several methodological 
inconsistencies. 
 Future studies should employ more rigorous and standardised methodologies to 
investigate sedentary behaviour in RA.  
 
Introduction 
Sedentary behaviour: definition and health relevance 
The term sedentary behaviour (SB) - derived from the Latin term sedere, meaning to sit – and 
is often simply defined as too much sitting [1].  Until recently, a common misapprehension 
has been that SB merely reflects the absence of purposeful physical activity, defined as 
moderate activity of ≥ 3 metabolic equivalents (METS, 1 MET =oxygen consumed at rest 
i.e., 3.5 mL/kg-1.min-1; 3 METS reflects moderate paced walking). However, a lack of 
moderate intensity physical activity should be referred to, more accurately, as physical 
 inactivity [2]. Indeed, current thinking recognises that SB and physical inactivity are separate 
constructs, and can be operationalised as such.  
In 2012, the Sedentary Behaviour Research Network (SBRN) defined SB as any 
waking behaviour characterised by activity of ≤1.5 METS and a sitting or reclining posture 
(e.g., television (TV) viewing, computer use, reading and driving) [2]. In contrast, physical 
inactivity is defined as insufficient/irregular engagement in moderate intensity activity of ≥3 
METS towards recommended levels (i.e. 60 minutes/day for adults) [3]. Thus, physically 
inactive individuals can also be non-sedentary, where, in the absence of moderate intensity 
activity, they still engage in substantial amounts of light physical activity (i.e., 1.6 –2.9 
METS) and spend little time sitting [3, 4]. Similarly, sedentary individuals can also be 
physically active, i.e., they spend large portions of the day sitting but engage in the 
recommended 60 minutes of MVPA each day (Figure 1). 
This move towards a more consistent thinking with regards to the modern 
conceptualisation of sedentariness is born out of recent findings demonstrating that SB holds 
deleterious consequences for health independently of any beneficial effects of physical 
activity engagement [4-11]. In particular, there is evidence that implicates SB as a precursor 
of heightened systemic inflammation in both healthy and clinical populations, irrespective of 
levels of the anti-inflammatory effect of physical activity [8-11]. Indeed, there now exists a 
considerable amount of evidence demonstrating SB to be an independent risk factor for 
cardiovascular disease, the metabolic syndrome, sarcopenia and Type 2 diabetes, all of which 
have chronic systemic inflammation in common[9,10,12-16]. These independent health 
effects may result from differences in the acute and chronic physiological responses to 
sedentary behaviour vs. physical activity engagement[17]. Indeed, divergent cellular 
mechanisms are reported to underlie the decrease in lipoprotein lipase (LPL) activity that can 
occur in response to sedentary behaviour, compared to the increase in LPL observed during 
 physical activity. For example, LPL activity is ≥10-fold lower in red oxidative muscle fibres 
during sedentary behaviour, whereas a 2.5 fold increase in LPL activity is observed in white 
glycolytic muscle fibres after exercise. Similarly, LPL mRNA expression is increased in 
glycolytic muscles in response to physical activity, where no change is observed in mRNA 
expression following prolonged sitting [18-20]. Low levels of LPL are associated with 
increased levels of circulating triglycerides and decreased levels of high-density lipoprotein 
cholesterol (HDL-C)[18,21] - precursors of inflammation and contributors to the progression 
of cardio-metabolic and cardiovascular disease[22,23]. Thus, evidence points to the 
possibility that regulation of LPL activity might represent a key cellular mechanism 
underling the independent associations between sedentary behaviour, inflammation and 
adverse health outcomes.  
Given that many individuals spend the largest proportion of the day being sedentary 
(e.g., 55–60% of waking hours) [24], reducing sitting time and sedentary behaviour change 
have become public health priorities for chronic disease prevention [1,3]. Consequently, an 
increasing number of large-scale cohort studies continue to advance our understanding of the 
determinants and health consequences of SB [8,25-27]. However, whilst research in this 
domain continues to grow exponentially from an epidemiological perspective, far less work 
has focussed on specific clinical cohorts.  
Examining the relevance of SB for health outcomes in individuals for whom physical 
dysfunction may contribute towards increased sedentariness, particularly those for which 
inflammation comprises a substantial component of disease aetiology, is obviously important. 
A prime example of such a clinical population is individuals living with Rheumatoid Arthritis 
(RA) for whom inflammation is a chief contributor towards disease progression, functional 
disability and other adverse outcomes. Indeed, high levels of SB which may result from 
reduced functional ability and persistent fatigue, may perpetuate the adverse consequences of 
 an already heightened chronic inflammatory load, and further contribute towards the risk of 
cardiovascular disease, metabolic syndrome and inflammation-related cachexia.  
Sedentary behaviour and Rheumatoid Arthritis  
Sedentary-inflammation hypothesis 
RA is a chronic autoimmune disease characterised by high-grade systemic and local 
inflammation, joint erosion, musculoskeletal deterioration and functional disability [28].  
Common sequela of uncontrolled high inflammatory load in RA include joint pain and 
stiffness, fatigue, compromised psychological wellbeing (e.g. depression), reduced quality of 
life, high CVD risk, and cachexia, amongst others[29-38]. 
Since SB may relate to increased inflammation, it follows that it may hold 
implications for such RA features. This may lead to a vicious cycle, where compromised 
physical function, heightened fatigue and increased local disease activity, may increase 
sedentariness, which, in turn, may further exacerbate inflammation and contribute towards 
the severity of RA-related health outcomes[39]. Figure two describes the proposed pathways 
by which the cyclic relationship may occur, and underpins the need for more research into the 
implications of SB for people with RA. 
In this article we consider sedentary behaviour specifically in the context of RA. We 
discuss current approaches utilised to measure it, summarise available data concerning its 
levels and health-related correlates in RA, highlight directions for future research, and 
provide recommendations for researchers pursuing work in this field. 
Measurement of sedentary behaviour 
The established definition of SB stipulates a consideration of both low energy 
expenditure ≤1.5 METS AND a sitting or reclining posture[2]. Thus, in order to accurately 
quantify levels of SB, measures should enable valid and reliable assessment of both the 
energy requirements of the activity and posture (i.e., whether sitting, reclining and standing). 
 Moreover, assessment methods should be validated for measurement of SB among the 
specific populations in which they are used. Assessment tools should also enable continuous 
data monitoring to permit the measurement of free-living SB, and include the ability to 
distinguish sleep from sedentary behaviours engaged in during waking hours. Finally, the 
ideal measure of SB would be low cost, easy to use by participants, and produce data that are 
easily analysed by researchers [40].   
When deliberating the utility of different measurement approaches it is also important to 
appreciate the components of SB proposed to be relevant to health [41]. It is not only the total 
amount of sedentary time accumulated that may hold implications for health-related 
outcomes, but also the manner in which it is accumulated. Specifically, the number and 
length of sedentary bouts (uninterrupted sedentary periods), and the frequency of 
interruptions in sedentary time (sedentary breaks), have been linked to biomarkers of chronic 
disease in both clinical and non-clinical populations [8-10,26]. For example, prolonged 
sedentary bouts are adversely associated with C-reactive protein, triglycerides, HDL-C and 
plasma glucose [9,10,26], where more frequent sedentary breaks associate with beneficial 
changes to the levels of these biomarkers[8,9]. The importance of examining the contribution 
of specific behaviours to total sedentary time has also been underlined: certain sedentary 
behaviours, such as TV viewing, may be more detrimental to physical health than others [8].  
Indeed, concurrent engagement in other unhealthy activities whilst participating in more 
passive (relative to mentally-active) sedentary activities has been reported to result in 
increased adiposity and poorer cardio-metabolic health (e.g., TV time snacking)[42]. 
Accordingly, the health-related constituents of SB have been conceptualised using the SITT 
formula as follows [43]; SITT – Sedentary behaviour frequency (number of bouts of certain 
duration)’; SITT – Interruptions (e.g., frequency of getting up during sedentary time); SITT – 
Time (duration of sedentary behaviours); SITT – Type (mode or context of sedentary 
 behaviour). In the following sections, we provide information regarding the advantages and 
disadvantages of different SB measurement approaches which are currently used to assess 
one of more components of SITT (Tables 1 and 2), including a focus on the application and 
validity of measures used in RA studies (Table 3).  
Current sedentary behaviour measurement methods 
Overview  
Tables 1 and 2 provide an overview of current sedentary behaviour measurement methods. 
The cost, and user-reported ease and burden of use for each are described (Table 1), as well 
as the ability of each measure to assess SITT components, and the reported validity and 
reliability of instruments (Table 2). The capability offered by objective measures to assess 
each facet of SB (sedentary energy expenditure and posture as per the SBRN definition) is 
also indicated (Table 2). 
Self-report methods 
Until recently, questionnaire-based methods have been most frequently used to 
investigate SB due to their low cost, low participant burden and ease of use[41] (Table 1). In 
general, questionnaires involve asking individuals to retrospectively estimate their total 
sitting Time (SITT) and/or time spent in specific Types (SITT) of sitting behaviours (e.g., TV 
viewing). Diaries can also be used to gather information in this way, on the basis of time-
referenced recall of behaviour (e.g., at the end of each day). However, the pervasive and 
varied nature of sedentary behaviours undertaken throughout the day, may limit the accuracy 
of recall. As a result, low validity and reliability are frequently observed with regards to 
retrospective self-report measurement methods (Table 2) [40,41,44].  
 To alleviate some of the problems associated with behavioural recall (e.g., social 
desirability [41]), diary-based methods that require repeated momentary time sampling (e.g., 
every 15 minutes), can be employed to gather real-time accounts of sedentary Time (SITT) and 
 Type (SITT). A clear advantage of this approach (coined Ecological Momentary Assessment, 
EMA[45]) is that it enables assessment of behaviour as it occurs. However, the time taken to 
complete EMA, and the advanced statistical data processing needed to analyse the data 
collected, means this method results in moderate-to-high burden for both the participant and 
the researcher. Still, the contextual data collected via EMA may also provide valuable insight 
with regards to the social and physical environmental factors predictive of sedentary Time 
(SITT) and Type (SITT) among different populations.  
Objective methods 
Addressing some of the limitations inherent in self-report, attention is shifting 
towards technological innovations in objective monitoring of SB, such as accelerometers - 
and to a lesser extent - posture sensors [40,41,46]. Accelerometers are small, lightweight 
devices, usually worn on the wrist, hip or upper arm, which enable data pertaining to 
movement patterns (e.g., trunk, wrist or ankle accelerations) to be recorded continuously over 
several days. Movement data recorded by devices are typically calibrated against energy 
expenditure assessed via indirect calorimetry in order to identify a sedentary threshold or cut-
point at which accelerometer output (e.g., signal magnitude vector – gravity subtracted, or 
accelerometer activity counts [47]), can be interpreted to classify behaviours requiring ≤ 1.5 
METs [48-50]. Continuous behaviour monitoring via accelerometry therefore enables 
measurement of Sedentary (SITT) bout frequency, sedentary time Interruptions (where activity 
counts cross the sedentary threshold) and sedentary Time (SITT). Still, whilst offering a 
somewhat comprehensive assessment of SITT components, it is not clear which sedentary 
cut-point should be employed in studies of different populations. Currently, a threshold of 
<100 counts per minute (cpm) is almost universally used to represent sedentary time among 
diverse cohorts [41]. However, this cut-point – derived from calibration studies of healthy 
adults [39] – has not been validated among different groups for whom the energy 
 requirements of behaviour may vary substantially (e.g., older adults and patient groups)[51]. 
Indeed, where accelerometers have been used to measure physical activity engagement, it is 
common for researchers to develop and validate specific cut-points to classify different 
intensities of physical activity among different populations [52,53].  
A further drawback of using accelerometers to quantify sedentary behaviour on the 
basis of accelerations/movement counts, is that non-sedentary activities requiring little 
movement may be misclassified as sedentary. For example, accelerometers may yield 
movement counts associated with sedentary activity (i.e.,<100cpm), during activities where 
energy expenditure is increased above sedentary levels (e.g., standing whilst lifting weights). 
Researchers have sought to overcome this limitation with the application of combined 
sensors that measure both movement and physiological response to activity (e.g., via heart 
rate, skin temperature)[54,55]. Still – even when combined with physiologic sensory ability – 
accelerometers lack the facility to accurately capture whether activities are undertaken whilst 
sitting/lying (i.e., sedentary) or standing (non-sedentary).  
Posture sensors represent a recent advancement in sedentary behaviour research and 
are being used with increasing regularity in this field [46]. These devices are typically worn 
on the front of the thigh, and use accelerometer-derived information regarding thigh position 
(towards gravity) to determine posture classification (i.e.,time spent sitting/lying/standing). 
Available evidence suggests posture sensors, such as the activPAL, may offer a valid 
measure of Sedentary (SITT) bout frequency, sedentary time Interruptions (SITT) and sedentary 
Time (SITT) [56]. Still, it is important to recognise that with the application of posture 
sensors, sedentary energy expenditure is inferred indirectly based on the assumed energy cost 
of sitting/lying (i.e., ≤1.5 METS)[46]. Thus, when used in isolation, both postural sensors and 
accelerometers are both limited in the extent to which they can accurately measure 
sedentariness in alignment with the SBRN definition. 
  Multi-site monitors - such as the Intelligent Device Energy Expenditure and Activity 
monitor (IDEEA) and the Dynaport Activity Monitor (DAM) - may offer a novel solution to 
this challenge [57]. These devices use multi-site sensor attachment (e.g., on the waist and the 
thigh) to determine time spent lying, reclining, sitting, standing, and in locomotion, as well as 
the energy cost (METS, IDEEA) or movement intensity (meters/second
2
, DAM) of activities 
[57,58]. However, the high cost of multi-site monitors combined with the high participant 
and researcher burden, means these instruments have not been employed extensively to study 
SB. Continued development of these approaches and subsequent validation work will help to 
confirm their effectiveness for measuring SB in different populations.   
Application and validity of sedentary behaviour measurement methods in RA 
Table 3 outlines the self-report methods and objective measurement methods currently 
employed to investigate sedentary behaviour in RA, and summarises results from studies that 
have examined measurement validity [56,59-61]. Preliminary work in this field suggests that 
overall, self-report instruments may not provide a valid assessment of time spent sedentary 
for people living with RA. Specifically, when compared to accelerometry, the Yale Physical 
Activity Survey (YPAS) and the International Physical Activity Questionnaire (IPAQ) are 
subject to substantial underreporting of sedentary time engagement in this patient 
group[59,60]. 
 Considering objective measurement approaches, the activPAL has been found to offer 
an accurate assessment of time spent sitting, lying, standing and walking in people living 
with RA, when compared to direct observation. However, its validity for quantifying step 
count and the number of sedentary time interruptions has been queried (i.e., underestimation 
by 26% and 36%, respectively)[56]. The validity of the Sensewear Armband (SWA) has also 
been examined, with data indicating this device to underestimate sedentary time in RA (as 
computed using manufacturer-derived proprietary algorithms) when compared with energy 
 expenditure assessed via indirect calorimetry[61]. This underestimation was suggested to be 
due to the elevated resting energy expenditure observed in this patient population, relative to 
healthy adults in which the proprietary-SWA-algorithms tested were developed[61]. As such, 
these findings support the thesis that inaccuracies in sedentary time estimation may arise 
when studies in RA employ SB algorithms derived from calibration studies in healthy adults 
(e.g.,<100cpm –Table 3)[59,60,62,63]. 
 Further perpetuating challenges surrounding SB measurement validity, discrepancies 
also arise with regards to the sedentary MET definition applied in RA studies. Specifically, 
whilst most studies in other populations have defined sedentary behaviour as ≤1.5 METS in 
line with the SBRN definition (based on <100cpm), recent research in RA has considered 
activities requiring ≤1 MET to represent sedentary activities[63,64]: it is therefore likely that 
common seated behaviours with an energy cost of between 1-1.5 METS (e.g., sitting and 
reading/typing/watching TV) are not captured in these studies[65-67]. Thus, the prevalence 
of sedentarity in RA may have been significantly underestimated in this work. Moreover, the 
application of inconsistent definitions of SB precludes comparisons across studies (of both 
RA and non-RA populations), hindering advancement in the understanding of SB 
epidemiology in this patient group. 
Against this background, in the following sections, we describe the results of current 
research that has sought to investigate levels and health related correlates of SB in RA. We 
critically appraise the measurement approaches used, analytical decisions employed and how 
these may have impacted upon results reported and their interpretation.  
 
 
 
 
 Levels and health correlates of sedentary behaviour in RA 
Levels of sedentary behaviour  
Self-reported 
Table 4 includes the results of the seven studies that have sought to measure levels of 
sedentary behaviour in RA using self-report [58-60,62-64,68-76]. Semanik and colleagues 
(2004) were among the first to investigate levels of SB in RA: using the YPAS, 48% of 
participants reported sitting for >6 hours/day [73]. More recently, Gilbert et al. (2015) – also 
using the YPAS – found that people with RA spend approximately 13 hours sitting/day, with 
53% reporting >8 hours daily sitting time [60]. This is substantially higher than estimates of 
sedentary time observed in the majority of other self-report studies, which show 4-6 hours 
sitting/day in RA. There may be several reasons for such divergent results including different 
populations of RA patients studied, the time period during which studies were conducted, and 
the manner in which sitting time was estimated. For example, Yu et al. (2015) and Greene et 
al., (2006) relied on participant recall of total daily sitting time in their studies using the 
IPAQ and PADS respectively[59,72]. In contrast, Gilbert and colleagues (2015) calculated 
daily sitting time as: 24 hours, minus the sum of self-reported physical activity and sleep 
time[60].  In addition, we have proposed a cyclical relationship between inflammation, 
sedentariness, and further perpetuation of inflammation[39]. With this in mind, it is also 
important to consider that the higher estimates of sitting time observed in some studies might 
reflect elevated disease activity and/or a longer disease duration of the particular patient 
sample studied. Indeed, comparison of descriptive data indicates patients recruited by Gilbert 
et al., (2015) represented individuals with active disease (DAS-28 =6.44) and established RA 
(13.4 years)[60]. In contrast, studies reporting relatively lower estimates of sedentary time 
engagement included patients with less active disease (e.g., DAS-28 =2.6)[68], and shorter 
disease durations (e.g.,7.2 and 11 years)[59,68]. 
 Despite evidence demonstrating specific sedentary behaviours to be particularly 
detrimental to health (e.g., TV viewing)[8], only two studies have distinguished between 
types of behaviour when assessing sedentary time accumulation in RA. Kramer et al., (2012) 
and Giles et al., (2008) reported TV viewing to occupy around 2 hours/day in people with 
RA[70,71].  
Objectively assessed 
Munneke and colleagues (2001) were the first to investigate the prevalence of 
objectively assessed sedentary behaviour in RA using the DAM (Table 4)[58]. Results 
indicated that over a 24-hour period, people with RA spent approximately 30.5% of time 
sitting and 42.1% lying. However, this study did not determine the MET costs associated 
with engagement in these activities. Rather, movement intensity was reported in units 
pertaining to speed and velocity (i.e., meters/second
2
)[77] Analyses also did not distinguish 
waking SB from sleep time, which may have resulted in inflated SB estimates. The 
distinction between waking SB vs. sleep is certainly important to make[40].  That is, sleep is 
a vital restorative process and should not be counted as sedentary time when examining 
levels and health related concomitants of SB.  
Following this initial work, it was over a decade later when other researchers begun to 
employ objective devices to estimate daily sedentary time in RA. In sum, these studies report 
between 9 and 19 hours sedentary time each day in people with RA (Table 
4)[59,60,63,64,76]. These highly variable estimates are again most likely due to 
methodological discrepancies, including: the instrument used (e.g., GT3X vs, RT3 
accelerometer vs. activPAL), the manner in which sedentary behaviour is defined and 
subsequently quantified (e.g.,<100cpm (equating to ≤1.5 METS), vs. ≤1 MET vs. time 
sitting/lying) and the data collection protocol (e.g., inclusion vs. exclusion of sleep time) 
(Table 4). However, a lack of detailed reporting with regards to sedentary 
 measurement/analysis protocols within studies, means the extent to which each of these 
factors may contribute towards differing sedentary time estimates in RA is difficult to 
establish[59,63,64,74,75].  
Health correlates of sedentary behaviour in RA 
Several recent studies have sought to examine health related correlates of sedentary 
behaviour for people living with RA, including associations with disease activity, physical 
function, muscle density, bone mass, and cardiovascular risk[59,63,70-72,75].  
Disease activity  
One study has examined the link between SB and RA-associated disease activity. In a 
cross-sectional study, Khoja et al., (2016) reported SB measured by the SWA, to be inversely 
related to disease activity score in a group of RA patients[63]. However, as with all cross-
sectional studies, the causal direction of this association cannot be determined. Indeed, SB 
could represent both a consequence and a cause of increased disease activity in RA[78-80]. 
That is, early RA patients, and/or patients with controlled disease, may be better able to avoid 
excess sedentarity, relative to individuals with established RA and/or more active disease. 
Prioreschi et al., (2014) examined longitudinal associations between SB and several health 
outcomes in RA. They reported reductions in SB alongside declines in morning stiffness 
following DMARD therapy[75]. Such findings underline the need of carefully designed 
longitudinal studies that could address issues of directionality/causality of associations 
between inflammation, SB and different health outcomes in RA.  In a similar vein, studies 
which compare the treatment efficacy of biologic therapies vs. more conventional synthetic 
DMARDs for concurrently attenuating disease activity and sedentary behaviour would offer 
an interesting research agenda.  
 
 
 Muscle density and functional disability 
Greene et al., 2006, were the first to report negative consequences of SB in RA, 
demonstrating self-reported time spent sitting and lying to be associated with disability and 
pain[72]. Giles et al., (2008) later showed self-reported daily TV time to associate with 
deleterious consequences for functional ability in RA[71]. Specifically, this cross-sectional 
study revealed each hour of TV viewing per day, was associated with a 0.09 unit increase in 
functional disability. The subsequent findings of Kramer et al. (2012) showed that TV 
viewing was negatively related to total muscle density, while total muscle density was 
positively associated with functional ability. Thus suggesting decreased muscle density as a 
plausible mechanism underlying this association[70]. Findings such as these support the 
hypothesis of a sedentary-inflammation pathway in RA, and require further investigation: 
sedentary time may exacerbate inflammation-induced cachexia, a chief contributor towards 
reduced muscle density and associated declines in physical function in RA[81]. 
Bone mass 
A recent study indicates SB may also be linked to lower bone mass in RA[62], 
holding implications for the development of osteopenia and subsequent osteoporosis. 
Prioreschi et al., (2015) reported patients with below average bone mass accrued 2 hours 
more accelerometer-assessed sedentary time each day (defined as <100cpm), than those with 
a normal bone mass[62]. The role of pro-inflammatory cytokines have been underlined in the 
development of osteoporosis in RA, with evidence for the efficacy of biologic therapies 
targeting inflammatory cytokines protecting against bone degradation[82]. Heightened local 
and systemic inflammation resulting from SB in RA, may therefore also contribute towards 
increased risk of osteoporosis in these patients.  
 
 
 Cardiovascular risk 
Khoja et al. (2016) also reported detrimental associations of SB with a number of 
cardiovascular risk factors (i.e., body-mass-index, blood pressure, insulin resistance, 
cholesterol), as well as functional disability in RA[63]. However, given that sedentary 
behaviour was defined as activities ≤1 MET in this study, conclusions could not be drawn 
concerning the relevance of common sedentary behaviours requiring 1–1.5 METS (e.g., 
sitting and reading a book or newspaper) for CV risk and other specific outcomes. 
Nevertheless, Yu et al, (2015) reported in a recent cross-sectional study, that accelerometer-
assessed SB (defined as <100cpm/≤1.5 METS) was negatively related to cardiorespiratory 
fitness in RA[59].  
Future research recommendations and directions:   
Research to date suggests high levels of sedentariness in people living with RA, which 
appears to be a significant contributor to their disease burden. However, to further our 
understanding of SB and its health consequences in this patient group, a great deal of work 
that employs a more rigorous approach specific to RA is required.  
Considering the methodological shortcomings and inconsistencies among past SB 
research in RA, we propose a standardisation of methodology that could include the 
following components: first, the definition of SB as advocated by the SBRN should be 
employed consistently across studies; second, a combination of self-report (e.g., diaries) and 
objective measures of SB should be utilised to effectively examine the multiple constituents 
of SITT; third, objective devices ought to include where possible, a measure of both posture 
and energy expenditure; fourth, studies employing accelerometry should utilise validated cut-
off points commensurate with activities characterised by ≤1.5 METS in people living with 
RA. Where possible disease-state specific cut-points (e.g.,early vs. established RA, active vs 
 inactive RA) should also be developed/validated to take into account inflammatory/metabolic 
variability observed within RA; fifth, SB accumulated during waking hours should be 
distinguished from time sleeping; sixth,  there should be clarity about data collection 
protocols and analytical decisions employed (e.g., cut-off points/algorithms used). 
On the basis of such recommendations, future research priorities in the field of SB in RA 
should include: first, validation of self-report instruments, and lab-based 
calibration/validation studies of objective devices for measurement of SB in RA – to include 
characterisation of the energy cost of common sedentary behaviours (i.e., activities 
undertaken whilst sitting and lying) and standing without ambulation; second, application of 
validated devices to enable accurate measurement of levels of SB in RA, including patterns 
of sedentary time accumulation as conceptualised by SITT; third,  Studies designed 
specifically to examine the directionality (including bi-directionality) of links between SB, 
inflammation, physical and psychosocial health outcomes in RA – with particular emphasis 
on disease activity, rheumatoid cachexia, and cardiovascular risk profile. These should also 
examine whether associations with such health outcomes occur independently of levels of 
light, moderate and vigorous physical activity engagement. 
We would like to emphasise that as yet, no studies have examined the implications of SB 
for psychological health and wellbeing in RA. This is perhaps due to the assumption that 
sedentary behaviour may contribute towards adverse health outcomes in these patients via 
physiological (e.g., inflammation) rather than psychological mechanisms. We therefore 
propose a parallel research agenda concentrated on investigating the contribution of sedentary 
behaviour to adverse psychological health outcomes in RA (e.g., depression, subjective 
vitality). 
 
 
 Conclusions 
Sedentary behaviour has emerged as a major contributor to the risk of developing and the 
outcome of chronic disease independently of engagement in physical activity.  Evidence 
indicates this is likely due to the heightened systemic inflammation resulting from high levels 
of sedentariness.  The potential relevance of SB for health outcomes in RA is of obvious 
importance and notwithstanding methodological difficulties that can be resolved, should be 
investigated further. Such research may inform the development of effective sedentary 
behaviour change interventions, which are likely to improve health and enhance quality of 
life in people with RA.  
Review criteria 
 
This manuscripts cited in this review (Table 4) were found by searching the terms sedentary 
and rheumatoid arthritis in PubMed (up to January 2016).  The search returned 55 
manuscripts. An additional search with the terms sitting and rheumatoid arthritis returned a 
further 3 manuscripts (after cross-checking for duplicates). Abstracts and full texts were 
reviewed by the main author, to determine the definition and measurement of sedentary 
behaviour employed. Studies retained for inclusion in this review are those that defined 
sedentary behaviour as distinct from physical inactivity (i.e., a lack of purposeful/health 
enhancing physical activity above a moderate intensity), and operationalized sedentary 
behaviour in accordance with either low energy expenditure (i.e., ≤1.5 or ≤1 MET) or 
behaviours undertaken in a sitting or reclining posture. All procedures were in line with 
published guidelines for writing a narrative review [83]. 
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Figure 1. Sedentary behaviour vs. physical inactivity 
Four distinct behavioural profiles representing different levels of engagement in sedentary 
behaviour, light physical activity and moderate-to-vigorous physical activity. Physically 
activity: meeting guidelines for moderate-to-vigorous physical activity (children= 60 minutes 
x 7 days/week, adults= 30 minutes x 5 days/week). Physically inactive: absence of 
engagement in recommended levels of moderate-to-vigorous physical activity. Sedentary: the 
majority of waking time spent in activities ≤1.5 METS and a sitting or reclining posture.  
  
Figure 2. Hypothesised sedentary behaviour-inflammation pathway in the context of 
RA 
Proposed cyclic relationship between sedentary behaviour, local and systemic inflammation 
and the progression of RA outcomes. TNF-α: tumor necrosis factor alpha.  
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Table 1. Existing sedentary behaviour measurement methods: cost, ease of use and burden 
Measure Perceived advantages/disadvantages  
Approach Type Example  Cost Ease of 
use 
Participant 
burden 
Researcher 
burden 
Subjective Questionnaires IPAQ, MOST + + + + + + 
 Diaries  Bouchard Physical 
Activity Record 
+ + + + + + + 
Objective Accelerometers Actigraph + + + + + + + + 
 Posture 
monitors 
ActivPAL + + ++ + + + + 
 Combined 
sensors         
Sensewear Armband + + + + + + + + + 
 Multi-site 
monitors 
IDEEA monitor + + + + + + + + + + 
+: low; ++; moderate; +++: high; IPAQ: International Physical Activity Questionnaire; MOST: Measure of Older adults 
Sedentary Time; IDEEA: Intelligent Device for Energy Expenditure and Activity monitor.  
  
Table 2: Reliability and validity of sedentary behaviour measurement methods 
 
 Ability to measure SITT 
components 
Validity and reliability for measuring SITT component 
(in the general population) 
Ability to (objectively) 
assess SB 
Type of 
measure 
SITT SITT SITT SITT Reliability Validity Criterion standard 
used for validation 
Sedentary 
activity 
METS 
Posture 
Questionnaires N N Y N + +/+ + + 
(higher for TV 
viewing only) 
+/+ + 
(higher for TV 
viewing only) 
Accelerometer,             
Posture monitor 
 
Diaries N N Y Y No detailed 
information 
No detailed 
information 
Accelerometer,            
Posture monitor 
  
Accelerometers Y Y Y N + +/+ + + 
(≥ 5 - 7 days of 
monitoring at ≥ 
10 hours/day) 
No consensus 
on cut-point to 
define sedentary 
time 
Indirect calorimetry     
Posture monitor                 
Y N 
Posture 
monitors 
Y Y Y N No detailed 
information 
+ + +           
(limited studies 
at present) 
Direct observation N Y 
Combined 
sensors         
Y Y Y N No detailed 
information 
No detailed 
information 
Indirect calorimetry       
(EE of sedentary 
activity) 
Y N 
Multi-site 
monitors 
Y Y Y N No detailed 
information 
+ + +            Indirect calorimetry      
(EE of sedentary 
activity) 
Direct observation 
(posture) 
Y Y 
 Y: yes; N: no; +: low; ++: moderate; +++: high; SITT: Sedentary behaviour frequency; SITT: interruptions; SITT: Time; SITT: 
Type; IPAQ: International Physical Activity Questionnaire; IDEEA: Intelligent Device for Energy Expenditure and Activity 
monitor; EE: energy expenditure.  
 
  
Table 3: Existing sedentary behaviour measurement methods: application and validity in RA 
Type of 
measure 
Measures used 
in RA 
Validation 
study in RA 
Number 
of studies 
Criterion standard 
for validation 
Conclusion 
Questionnaires  YPAS Y 2 Accelerometer            
(<100 cpm) 
Underestimates 
sedentary Time 
LTPA Level 
Questionnaire 
N 1 ----- ----- 
PAS N 1 ----- ----- 
IPAQ Y 1 Accelerometer            
(<100 cpm) 
Underestimates 
sedentary Time 
7-day PARQ N 2 ---- ---- 
PADS N 1 ---- ---- 
Diaries None  N/A  ---- ---- 
Accelerometers Actical N 2 ---- ---- 
Actigraph N 3 ---- ---- 
RT3 N 1 ---- ---- 
Posture monitors ActivPAL Y 1 Direct observation Underestimates 
sedentary Interupptions 
Valid for measurement 
of Sedentary behaviour 
frequency and Time 
Combined 
sensors           
Sensewear 
armband  
Y 1 EE assessed via 
indirect calorimetry 
Underestimates 
sedentary Time 
Multi-site 
monitors 
DAM monitor N 1   
Y: yes; N: no; YPAS: Yale Physical Activity Survey; LTPA: Leisure Time Physical Activity; PAS: Physical 
Activity Survey; IPAQ: International Physical Activity Questionnaire; PARQ: Physical Activity Recall 
Questionnaire; PADS: Physical Activity Disability Survey; DAM: Dynaport Activities of Daily Living 
(monitor); cpm: counts per minute; EE: energy expenditure. 
  
Table 4: Studies using self-report and objective measures to determine levels of sedentary behaviour in RA 
Study Sample size 
(N = RA 
patients) 
Age, mean (SD) Measurement of 
sedentary behaviour 
Definition of sedentary 
behaviour 
Variables derived Levels of sedentary behaviour 
reported, mean ± SD  
Self-report 
studies 
      
Gilbert et al., 
2015 
N = 172 55.11 (13.91) YPAS Time spent sitting % participants sitting for; <3, 
3-6, 6-8 and >8 hours/day 
 
Daily sitting time continuous; 
(physical activity hours + 
sleep hours) – 24 hours 
53% reported >8 hours sitting 
time per day      
 
13 ± 2.59 hours/day sitting time  
(780 ± 155.40 min/day) 
Løppenthin et 
al., 2015 
N = 43 60 (range, 21–88) LTPA Level 
Questionnaire  
 
 
 
 
 
 
 
PAS 
Time spent primarily 
watching TV, reading 
books, other passive 
activities 
 
In your leisure time, how 
many hours/mins per day, 
do you watch TV, sit 
down and relax, read or 
listen to music etc.? 
 Sitting time (hours/day) 4 hours/day sitting time (range, 
3-5 hours) 
Yu et al., 2015 N = 68 55.00 (13.00) IPAQ Time spent sitting Sitting time (minutes/day) 290 ± 159 min/day sitting time 
(4.83 ± 2.65 hours/day) 
Kramer et al., 
2012 
N = 152 63.00 (8.00) 7-day PARQ Duration of TV viewing TV viewing (hours/day) 2 hours/day TV viewing 
(range, 1 – 3 hours) 
Giles et al., 
2008 
N = 197 59.40 (8.70) 7-day PARQ Duration of TV viewing TV (hours/day) 2.3 ± 1.6 hours/day TV viewing          
Greene et al., 
2006 
N = 52     61.00 (14.50)      PADS Time spent sitting/lying 
down 
Time spent sitting/lying 
(hours/day) 
5.6 ± 3.4 hours/day sitting/lying 
Seminak et al., 
2004 
N = 185  YPAS (On average, how many 
hours/day are you sitting 
or lying down, not 
counting when you sleep 
at night) 
% participants reporting; 
 
Sitting for > 6 hours/day 
 
 
Standing without movement 
for >3 hours/day 
 
 
48% reported sitting for >6 
hours/day 
 
75% reported standing without 
movement for >3 hours/day 
Objective 
studies  
      
Gilbert et al., 
2015 
N = 172  55.11 (13.91) GT3X accelerometer <100 cpm Sedentary time (hours/day) 9.86 ± 1.38 hours/day sedentary 
time  
(591.60 ± 82.80 min/day) 
Prioreschi et 
al., 2015 
N = 29 Low bone mass 
57.00 (12.00) 
Normal bone mass              
51.00 (10.00) 
Actical accelerometer ≤ 100 cpm Sedentary time (% waking 
hours/day) 
 
Sedentary time (min/hour) 
Between 65 ± 4 and 73 ± 2 % 
waking hours/day sedentary  
 
39.00 ± 6.00 to 44.00 ± 6.00 
min/hour sedentary 
Khoja et 
al.,2016 
N = 98 58.00 (9.00) Sensewear Armband Activities <1 MET Sedentary time (min/day)      
(including sleep time) 
589 min/day sedentary time 
(SD not reported in text) 
(9.8 hours/day) 
Yu et al., 2015 N = 68 55.00 (13.00) GT3X accelerometer (software algorithm not 
described) 
Sedentary time (min/day) 
(including sleep time) 
583.00 ± 98.00 min/day 
sedentary time  
(9.72 ± 1.63 hours/day) 
Huffman et al., 
2015 
N = 41 55.00 (48, 64) 
(25th, 75th centile) 
RT3 accelerometer <100 cpm Sedentary time (minutes/day) 
 
 
 
Sedentary time (% waking 
hours/day) 
854.4 min/day sedentary time     
(SD not reported in text)                      
(14.24 hours/day) 
 
92.1 (range 89.2 – 95.3)% 
waking hours 
Prioreschi et 
al., 2013   
N = 50 48.00 (13.00) Actical accelerometer Activities <1 MET Average counts spent in 
sedentary activity threshold  
(% waking hours/day) 
71 ± 11% of waking time spent 
in sedentary activities 
Prioreschi et 
al., 2014   
N = 18 50.00 (14.00) Actical accelerometer (software algorithm not 
described) 
Average number of activity 
counts spent in sedentary 
activity threshold per day 
428 ± 124 counts in sedentary 
activity per day 
Rafferty et al., 
2014 
N = 19 51.80 (12.50) ActivPAL     Actical software 
algorithms used and not 
described 
Time spent sitting/lying 
(hours/day)  
(including sleep time) 
18.83 ± 1.72 hours/day spent 
sitting/lying  
(1,130 min/day) 
Munneke et 
al., 2001 
N = 41  DAM monitor Actical software 
algorithms used and not 
described 
Time spent sitting (including 
sleep time) and being; 
 
non-active 
 
 
active -with trunk movement 
 
Time spent lying (including 
sleep time) 
 
 
 
30.5 ± 9.1% of time in non-
active sitting 
 
2.0 ± 1.1% of time in active 
sitting    
 
42.1 ± 8.8% of time lying 
YPAS: Yale Physical Activity Survey; LTPA: Leisure Time Physical Activity; PAS: Physical Activity Survey; IPAQ: International Physical Activity Questionnaire; PARQ: Physical Activity 
Recall Questionnaire; PADS: Physical Activity Disability Survey; METS: metabolic equivalents; DAM: Dynaport Activities of Daily Living (monitor); MET: metabolic equivalent; cpm: counts 
per minute. 
